Un-audited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2026

Outcome of Board Meeting held on August 13, 2026.

In compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, it is hereby informed that, the Board of Director approved the following: 1. Considered and Apporved the UFR of the Company for the quarter ended on 30th June, 2026. 2. taken on record the Limited Review Report (Standalone & Consolidated) pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015 submitted ny the statutory auditors of the Company.

Board Meeting Outcome for Adline Chem Lab Limited for Unaudited Standalone Financial Results For The Quarter Ended June 30, 2026.

Unaudited Financial Results for the Quarter ended on 30th June, 2026

Unaudited financial results approval in the BM held on 13.8.26 for the quarter ending 30.6.26

Un-Audited Financial Results of the Company for the Quarter ended June 30, 2026.

Unaudited Quareterly Results for Q.E. 30.06.2026

Financial Results for the quarter ended 30th June, 2026

Approval of unaudited financial results of the company for the quarter 30th June 2026